Bacterial Strains Used in This Study MIC [ mg = ml ] ciproﬂoxacin Source and reference Strain Description - Institut ef .

Salmonella Hadar D Clinical isolate , wild - type strain 0.015 Clinical isolate , gyrA : D87N Salmonella Hadar ( 96 - 07291 ) 0.5 - Institut Clinical isolate , gyrA : D87N Salmonella Hadar ( 97 - 13861 ) Salmonella Typhimurium DT104 C Salmonella Typhimurium DT104 ( 98 - 05405 ) Salmonella Typhimurium DT104 ( 97 - 04764 ) Salmonella Typhimurium DT204c ( 80190 ) 1 - Institut ef .

Primers Used in This Study ( Restriction Sites Are Underlined ) 50 - to - 30 DNA sequence of primer Primer name Restriction site GATATCTAGACTCACAATTTATGTGG CGCTGGAAGCTTATGTCATTCGCT AGCAAACCTTTACGCGCATT ATGCGTACGGCCATGCTT TGGCAATAAGGTGTGATCCG AGTTCTCCGACGTGACCGTT AGCCCAATGCCATCCTTGT GCTTCGACCTGGCTTTTATCG CGCACTGCCATTGGTGTTAT CTGGCTCATGACCAAACCG TGCCATGGAAGCCGGTTA CGTTGGCCAGTTGCTGCT rma_for ( oe ) rma_rev ( oe ) rma_for ( rt ) rma_rev ( rt ) acrA_for ( rt ) acrA_rev ( rt ) acrE_for ( rt ) acrE_rev ( rt ) mdtC _ for ( rt ) mdtC_rev ( rt ) tolC_for ( rt ) tolC_rev ( rt ) XbaI HindIII Table 3 .

MICs of Various Antibiotics After Overexpression of rma from Plasmid pPHB863 ( pBAD - rma ) in Salmonella Hadar D MIC [ mg = ml ] tet roxi ery novo spar moxi nor cip nal clm Salmonella Hadar D þ glucose ( 15 mM Salmonella Hadar D þ arabinose ( 15 m Salmonella Hadar D = pPHB863 þ glucose ( 15 mM ) Salmonella Hadar D = pPHB863 þ arabinose ( 15 mM ) ) 4 4 4 8 8 1 1 1 128 128 256 64 64 2048 2048 2048 0.03 0.03 0.03 0.06 0.06 0.12 0.06 0.06 0.06 0.015 0.015 0.015 M ) 16 128 256 256 16,384 0.24 16 32 12 0.5 1 0.12 8 MICs , minimum inhibitory concentrations ; cip , ciproﬂoxacin ; nor , norﬂoxacin ; moxi , moxiﬂoxacin ; spar , sparﬂoxacin ; nal , nalidixid acid ; clm , chloramphenicol ; tet , tetracycline ; novo , novobiocin ; ery , erythromycin ; roxi , roxithromycin 262 FEUERRIEGEL AND HEISIG 100 x-fold expression chang 80 81.6 60 40 20 16.7 16.2 15.8 13.7 0 rma acrA acrE mdtC tolC S.Hadar D / pPHB863 ( pBAD - rma ) + arabinose ( 15mM ) FIG. 1 .

x-Fold Expression Change of rma and acrA in Various Clinical Isolates of Salmonella Typhimurium DT104 and DT204c and Salmonella Hadar Compared to the Wild - Type Strains Salmonella Typhimurium DT104 C and Salmonella Hadar D x-Fold expression change ( mean value ) of clinical isolate compared to respective wild - type strain [ standard deviation in % ] MIC [ mg = ml ] ciproﬂoxacin GOI Clinical isolate 0.5 3.3 [ 19.6 ] 1.3 [ 4.5 ] 5.6 [ 8.2 ] 1 9.9 [ 11.8 ] 1.5 [ 13.7 ] 5.2 [ 12.9 ] 3.1 [ 12.9 ] 16.2 [ 12.1 ] 2.4 [ 19.2 ] Salmonella rma acrA rma acrA rma acrA rma acrA rma acrA Typhimurium D Salmonella Typhimurium D Salmonella Typhimurium D Salmonella Hadar ( 96 - 07291 ) Salmonella Hadar ( 97 - 13861 ) T104 ( 98 - 05405 ) 1 T104 ( 97 - 04764 ) 32 T204c ( 80190 ) 0.5 1 Work is in progress to identify other genes besides acrAB , acrEF , mdtABC , and tolC , which are additionally addressed by the global regulator Rma .

